Delivery Order SPE2DB20D2002-SPE2DB25FL56G
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Januvia 100 mg tablets (90-count) at a ceiling value of $1,066.44. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by June 3, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains its headquarters and primary...
- The Defense Logistics Agency awarded a $1,105.16 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Januvia 100 mg tablets in a 90-count package. This firm fixed-price contract, which is set to be completed by July 31, 2025, represents a single delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $1,091.46 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Januvia 100 mg tablets (90-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 19, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,717.61 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price contract, which is a child award under a larger indefinite delivery vehicle, represents a competitively awarded non-set-aside delivery order with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Januvia 100 mg tablets (90-count units) at a ceiling value of $1,091.46. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The product will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction supporting federal medical procurement needs. The contract carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $15,034.57 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 30, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $4,382.99 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a pharmaceutical supply transaction under AmerisourceBergen's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Januvia 100 mg tablets (90-count packages) valued at $4,365.84. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by September 30, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, which serves as the company's corporate...
- The Defense Logistics Agency awarded a $1,819.10 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed price delivery order, which is set to conclude by August 27, 2025, will be fulfilled from the vendor's operations in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the vendor's demonstrated capability to meet federal pharmaceutical procurement...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL56GDelivery Order
The Defense Logistics Agency awarded a $2,182.92 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price delivery order, with an ultimate completion date of July 15, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and critical federal healthcare vendor. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. The contract encompasses diabetes medications, specialty treatments, vaccines, and other critical medical commodities for use by the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 7/14/25 |